Indefinite Delivery Contract 36C24825D0014

Award Date 1/13/25
Last Date to Order 1/12/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BIOFIRE MOLECULAR TESTING products and services. The $209,568.78 contract, which has a period of performance through September 30, 2025, is under the VA's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. Biomerieux Inc., through its Biomerieux, Inc. division, will supply the VA with its...
This single-award Indefinite Delivery Contract (IDC) was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Biomerieux Inc., a global diagnostics manufacturer, to provide an Automated Blood Culture System and associated reagents. The $2,000,000 contract has a period of performance through September 30, 2025. Biomerieux will deliver its proprietary VITEK, BioFire, and VIDAS platforms, consumables, and technical support services to support...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) awarded a single-award Blanket Purchase Agreement (BPA) to Biomerieux Inc., a foreign-owned for-profit manufacturer, for the provision of BIOFIRE PANELS AND VERIFICATION KITS. The BPA has a ceiling value of $6,557,011.80 and a period of performance through September 30, 2025. This award facilitates the ongoing procurement of Biomerieux's proprietary diagnostic testing platforms and consumables, including...
The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 23 (VISN 23), has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of test kit reagents and associated diagnostic platforms. This single-award BPA, with a total ceiling value of $14,732,632.16, is part of Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a single award Indefinite Delivery Contract to Biomerieux Inc. with a potential value of $7.4 million to provide identification, antimicrobial susceptibility testing, and matrix-assisted laser desorption/ionization clinical proteomics technology solutions. The original solicitation posted on January 18, 2023 sought these laboratory diagnostic testing equipment and services with a...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) awarded a single-award Indefinite Delivery Contract (IDC) to Biomerieux Inc., a global leader in in vitro diagnostics, for bacterial identification and susceptibility testing services. The $2,366,377.51 IDC, awarded on April 1, 2021 without any set-aside designations, has an ultimate completion date of March 31, 2026. Under this contract, Biomerieux will provide its proprietary microbiology analyzers,...
Biomerieux Inc., a global leader in in vitro diagnostics, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23. The contract, valued at $135,660.00, is for the maintenance and support of Biomerieux's specialized diagnostic equipment and platforms installed at VA healthcare facilities. The contract has an ultimate completion date of September 30, 2027, with the first two task orders valued at...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 15 (VISN 15) has awarded a Blanket Purchase Agreement (BPA) contract to Biomerieux Inc., a global leader in in vitro diagnostics. The BPA, valued at up to $2,140,680.65 over its five-year period of performance, is for the provision of susceptibility testing products and services to support microbiology laboratory operations across the VISN 15 network of VA medical facilities in the...
The key elements of this federal contract Indefinite Delivery Vehicle (IDV) award are as follows: The Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 6 (VISN 6), awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, to provide its proprietary BioFire FilmArray diagnostic systems, associated test kits, and related services. The BPA has a total ceiling value of $6,300,000 and a period of performance through...
The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, to provide reagents and E-test strips. The contract has a ceiling value of $200,000 and a period of performance through September 30, 2025. This is a single-award BPA issued under the VA's Veterans Integrated Service Network 1 (VISN 1) to support the agency's clinical diagnostics and infectious disease testing requirements across its healthcare...
  • 36C24825D0014
    Indefinite Delivery Contract
  • 7
    Federal Contract Awards

The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Biomerieux Inc. for VISN 8 Molecular Pathogen Detection. The contract, valued at $31,825,821.12, has an ultimate completion date of January 12, 2030, and was awarded on January 13, 2025.

Under this IDC, Biomerieux Inc., through its Biomerieux, Inc. Division, will provide in-vitro diagnostic test panels, equipment, and related services to support molecular pathogen detection capabilities at seven VA medical centers across Florida and Puerto Rico. The contract covers a range of medical panels, including Gastrointestinal, Meningitis/Encephalitis, Joint Infection, Pneumonia, Blood Culture Identification, and Respiratory panels, utilizing the Biomerieux Biofire FilmArray Torch Multiplex PCR system or an equivalent technology. The contract does not involve any set-aside designations, as Biomerieux is the sole source provider for its proprietary diagnostics platforms. The initial task order, valued at $1,294,863.12, was awarded on January 13, 2025, with a completion date of September 30, 2025.

Generated 1/11/25, 9:05 AM